|
1
|
Qiu H, Cao S and Xu R: Cancer incidence,
mortality, and burden in China: A time-trend analysis and
comparison with the United States and United Kingdom based on the
global epidemiological data released in 2020. Cancer Commun (Lond).
41:1037–1048. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan P and Yeoh KG: Genetics and molecular
pathogenesis of gastric adenocarcinoma. Gastroenterology.
149:1153–1162.e3. 2015. View Article : Google Scholar
|
|
3
|
Zhang M, Zhong A, Liu H, Zhao L, Wang Y,
Lu Z, Zhang L, Pan X, Liang Z, Gao L, et al: EZH2 loss promotes
gastric squamous cell carcinoma. Nat Commun. 16:60322025.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tao B, Wang Z, Wang X, Song A, Liu J, Wang
J, Zhang Q, Chen Z, Wang Z, Xu W, et al: An inherited
predisposition allele promotes gastric cancer via enhancing
deubiquitination-mediated activation of epithelial-to-mesenchymal
transition signaling. J Clin Invest. 135:e1796172025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keller G, Grimm V, Vogelsang H, Bischoff
P, Mueller J, Siewert JR and Höfler H: Analysis for microsatellite
instability and mutations of the DNA mismatch repair gene hMLH1 in
familial gastric cancer. Int J Cancer. 68:571–576. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Richards FM, McKee SA, Rajpar MH, Cole TR,
Evans DG, Jankowski JA, McKeown C, Sanders DS and Maher ER:
Germline E-cadherin gene (CDH1) mutations predispose to familial
gastric cancer and colorectal cancer. Hum Mol Genet. 8:607–610.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu L, Mullins CS, Schafmayer C, Zeißig S
and Linnebacher M: A global assessment of recent trends in
gastrointestinal cancer and lifestyle-associated risk factors.
Cancer Commun (Lond). 41:1137–1151. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ajani JA, Lee J, Sano T, Janjigian YY, Fan
D and Song S: Gastric adenocarcinoma. Nat Rev Dis Primers.
3:170362017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsuoka T and Yashiro M: Bioinformatics
analysis and validation of potential markers associated with
prediction and prognosis of gastric cancer. Int J Mol Sci.
25:58802024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guan WL, He Y and Xu RH: Gastric cancer
treatment: Recent progress and future perspectives. J Hematol
Oncol. 16:572023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farin HF, Bussen M, Schmidt MK, Singh MK,
Schuster-Gossler K and Kispert A: Transcriptional repression by the
T-box proteins Tbx18 and Tbx15 depends on Groucho corepressors. J
Biol Chem. 282:25748–25759. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kispert A and Herrmann BG: The Brachyury
gene encodes a novel DNA binding protein. Embo J. 12:3211–3220.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmed A, Syed JN, Chi L, Wang Y,
Perez-Romero C, Lee D, Kocaqi E, Caballero A, Yang J,
Escalante-Covarrubias Q, et al: KDM8 epigenetically controls
cardiac metabolism to prevent initiation of dilated cardiomyopathy.
Nat Cardiovasc Res. 2:174–191. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye W, Wang Y, Hou S, Mei B, Liu X, Huang
H, Zhou Q, Niu Y, Chen Y, Zhang M and Huang Q: USF3 modulates
osteoporosis risk by targeting WNT16, RANKL, RUNX2, and two GWAS
lead SNPs rs2908007 and rs4531631. Hum Mutat. 42:37–49. 2021.
View Article : Google Scholar
|
|
16
|
Pan DZ, Miao Z, Comenho C, Rajkumar S,
Koka A, Lee SHT, Alvarez M, Kaminska D, Ko A, Sinsheimer JS, et al:
Identification of TBX15 as an adipose master trans regulator of
abdominal obesity genes. Genome Med. 13:1232021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li P, Li Y, Bai S, Zhang Y and Zhao L:
miR-4732-3p prevents lung cancer progression via inhibition of the
TBX15/TNFSF11 axis. Epigenomics. 15:195–207. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ge Y, Jia B, Zhang P, Chen B, Liu L, Shi
Y, Huang S, Liu X, Wang R, Xie Y, et al: TBX15 facilitates
malignant progression of glioma by transcriptional activation of
TXDNC5. iScience. 27:1089502024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan D, Yu Y, Ni Q, Meng Q, Wu H, Ding S,
Liu X, Tang C, Liu Q and Yang K: The overexpression and clinical
significance of TBX15 in human gliomas. Sci Rep. 13:97712023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Golozar M, Motlagh AV, Mahdevar M, Peymani
M, InanlooRahatloo K and Ghaedi K: TBX15 and SDHB expression
changes in colorectal cancer serve as potential prognostic
biomarkers. Exp Mol Pathol. 136:1048902024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu P and Wu LN: Sulforaphane targets the
TBX15/KIF2C pathway to repress glycolysis and cell proliferation in
gastric carcinoma cells. Nutr Cancer. 75:1263–1270. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei G: RNA m6A modification, signals for
degradation or stabilisation? Biochem Soc Trans. 52:707–717. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu Y, Gong C, Li Z, Liu J, Chen Y, Huang
Y, Luo Q, Wang S, Hou Y, Yang S and Xiao Y: Demethylase ALKBH5
suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Mol Cancer. 21:342022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shu F, Liu H, Chen X, Liu Y, Zhou J, Tang
L, Cao W, Yang S, Long Y, Li R, et al: m6A modification promotes
EMT and metastasis of castration-resistant prostate cancer by
upregulating NFIB. Cancer Res. 84:1947–1962. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Zhang J, Liu H, Meng L, Gao X,
Zhao Y, Wang C, Gao X, Fan A, Cao T, et al: N6-methyladenosine
reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer
chemoresistance in gastric cancer. Cancer Commun (Lond).
44:469–490. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin T, Yang L, Chang C, Luo H, Wang R, Gan
Y, Sun Y, Guo Y, Tang R, Chen S, et al: HnRNPA2B1 ISGylation
regulates m6A-Tagged mRNA selective export via ALYREF/NXF1 complex
to foster breast cancer development. Adv Sci (Weinh).
11:e23076392024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiao Y, Sun Q, Chen X, He L, Wang D, Su R,
Xue Y, Sun H and Wang H: Nuclear m6A reader YTHDC1 promotes muscle
stem cell activation/proliferation by regulating mRNA splicing and
nuclear export. Elife. 12:e827032023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alarcón CR, Goodarzi H, Lee H, Liu X,
Tavazoie S and Tavazoie SF: HNRNPA2B1 is a mediator of
m(6)A-dependent nuclear RNA processing events. Cell. 162:1299–1308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar :
|
|
30
|
Bokar JA, Shambaugh ME, Polayes D, Matera
AG and Rottman FM: Purification and cDNA cloning of the
AdoMet-binding subunit of the human mRNA
(N6-adenosine)-methyltransferase. RNA. 3:1233–1247. 1997.PubMed/NCBI
|
|
31
|
Zaccara S, Ries RJ and Jaffrey SR:
Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell
Biol. 20:608–624. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zeng Y, Luo Y, Zhao K, Liu SS, Wu KK, Wu
YY, Du KK, Pan W, Dai Y, Liu Y, et al: m6A-mediated induction of
7-dehydrocholesterol reductase stimulates cholesterol synthesis and
cAMP signaling to promote bladder cancer metastasis. Cancer Res.
84:3402–3418. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Fan P, Shen P, Fan C, Zhao P, Shen
Y, Dong K, Ling R, Chen S and Zhang J: XBP1s activates
METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation
in breast cancer. Cancer Lett. 596:2168462024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu Q,
Chen ZH, Zeng ZL, Wang F, Zheng J, et al: METTL3 facilitates tumor
progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal
carcinoma. Mol Cancer. 18:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Q, Guo X, Li L, Gao Z, Su X, Ji M and
Liu J: N(6)-methyladenosine METTL3 promotes cervical cancer
tumorigenesis and Warburg effect through YTHDF1/HK2 modification.
Cell Death Dis. 11:9112020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W,
Jiang X, Li H, Yang P and Xiang D: N6-Methyladenosine-Mediated
Up-Regulation of FZD10 regulates liver cancer stem cells'
properties and lenvatinib resistance through WNT/β-catenin and
hippo signaling pathways. Gastroenterology. 164:990–1005. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei X, Huo Y, Pi J, Gao Y, Rao S, He M,
Wei Q, Song P, Chen Y, Lu D, et al: METTL3 preferentially enhances
non-m(6)A translation of epigenetic factors and promotes
tumourigenesis. NaT cell Biol. 24:1278–1290. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu X and Li Y, Wu Y, Wang M, Lu Y, Fang Z,
Wang H and Li Y: Increased ATF2 expression predicts poor prognosis
and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox
Biol. 59:1025642023. View Article : Google Scholar
|
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
40
|
He Z, Jiao H, An Q, Zhang X, Zengyangzong
D, Xu J, Liu H, Ma L and Zhao W: Discovery of novel
4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis.
Acta Pharm Sin B. 12:291–307. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng Z, Lin F, Zhao B, Chen G, Wei G,
Chen X, Nie R, Zhang R, Zhao Z, Zhou Z, et al: ALKBH5 suppresses
gastric cancer tumorigenesis and metastasis by inhibiting the
translation of uncapped WRAP53 RNA isoforms in an m6A-dependent
manner. Mol Cancer. 24:192025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wei J, Yin Y, Zhou J, Chen H, Peng J, Yang
J and Tang Y: METTL3 potentiates resistance to cisplatin through
m(6) A modification of TFAP2C in seminoma. J Cell Mol Med.
24:11366–11380. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA,
et al: The immune landscape of cancer. Immunity. 48:812–830.e814.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Arribas J, Giménez E, Marcos R and
Velázquez A: Novel antiapoptotic effect of TBX15: overexpression of
TBX15 reduces apoptosis in cancer cells. Apoptosis. 20:1338–1346.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ogawa S, Kubo H, Murayama Y, Kubota T,
Yubakami M, Matsumoto T, Ohashi T, Okamoto K, Kuriki Y, Hanaoka K,
et al: Matrix metalloprotease-14 is a target enzyme for detecting
peritoneal metastasis in gastric cancer. Photodiagnosis Photodyn
Ther. 35:1024202021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kasurinen A, Gramolelli S, Hagström J,
Laitinen A, Kokkola A, Miki Y, Lehti K, Yashiro M, Ojala PM,
Böckelman C and Haglund C: High tissue MMP14 expression predicts
worse survival in gastric cancer, particularly with a low PROX1.
Cancer Med. 8:6995–7005. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen WC, Chang AC, Tsai HC, Liu PI, Huang
CL, Guo JH, Liu CL, Liu JF, Thuong LHH and Tang CH: Bone
sialoprotein promotes lung cancer osteolytic bone metastasis via
MMP14-dependent mechanisms. Biochem Pharmacol. 211:1155402023.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen M, Qu H, Liang X, Huang Y, Yang Z, Lu
P, Shi K, Chen P, Zhang Y, Zhou H, et al: Brachyury promotes
proliferation and migration of colorectal cancer cells by targeting
MMP14. Cancer Cell Int. 25:1322025. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Siska PJ, Singer K, Evert K, Renner K and
Kreutz M: The immunological Warburg effect: Can a
metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy?
Immunol Rev. 295:187–202. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate
pulmonary metastasis of mammary carcinomas by enhancing protumor
properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang H, Zhang Q, Xu M, Wang L, Chen X,
Feng Y, Li Y, Zhang X, Cui W and Jia X: CCL2-CCR2 axis recruits
tumor associated macrophages to induce immune evasion through PD-1
signaling in esophageal carcinogenesis. Mol Cancer. 19:412020.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Qian J, Li J, Ma H and Ji W: Exosomal
circ-ADRM1 promotes lung adenocarcinoma progression and induces
macrophage M2 polarization through regulating MMP14 mRNA and
protein. Anticancer Drugs. 34:333–343. 2023. View Article : Google Scholar
|
|
53
|
Ager EI, Kozin SV, Kirkpatrick ND, Seano
G, Kodack DP, Askoxylakis V, Huang Y, Goel S, Snuderl M, Muzikansky
A, et al: Blockade of MMP14 activity in murine breast carcinomas:
Implications for macrophages, vessels, and radiotherapy. J Natl
Cancer Inst. 107:djv0172015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen Q, Yin H, Jiang Z, He T, Xie Y, Mao
W, Han J, Liu S, Lou W, Wu W, et al: Poor clinical outcomes and
immunoevasive contexture in CD161+CD8+ T
cells barren human pancreatic cancer. J Immunother Cancer.
12:e0086942024. View Article : Google Scholar
|
|
55
|
Wang J, Zheng C, Lu J, Xu X, Xiang G, Li
J, Zhang J, Mu X and Lu Q: The mechanism of MMP14-positive
tumor-associated fibroblast subsets in inhibiting PD-1
immunotherapy for esophageal cancer through exosomal tsRNA-10522.
Funct Integr Genomics. 24:1862024. View Article : Google Scholar
|
|
56
|
Wang HM, Zhang XH, Ye LQ, Zhang K, Yang
NN, Geng S, Chen J, Zhao SX, Yang KL and Fan FF: Insufficient CD100
shedding contributes to suppression of CD8(+) T-cell activity in
non-small cell lung cancer. Immunology. 160:209–219. 2020.
View Article : Google Scholar : PubMed/NCBI
|
